Chemoprotomic and Automation dual-driving platform to expand undruggable target space and drug discovery
Business Model:
Revenue: $0
Employees: 51-200
Address:
City: Ningbo
State: Zhejiang
Zip:
Country: China
LeadArt Biotechnologies is accelerating drug discovery by automating chemoproteomics technology and creating the world’s largest human target-probe database. LeadArt Biotechnologies’ platform integrates biotechnology and automation technologies to discover disease-related targets and chemical probes for traditionally undruggable and unexplored targets. Headquartered in Ningbo and Boston, LeadArt is leading the digital transformation of drug discovery. LeadArt was founded in 2017 and backed by investors including BlueRun Ventures Aster.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2022 | Seed Round | 2 | $6M |
Blue Run Ventures China Yongchao Venture Capital Blue Run Ventures China Yongchao Venture Capital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|